386 related articles for article (PubMed ID: 25855392)
21. Myocardial tissue characterization in patients with hereditary gelsolin (AGel) amyloidosis using novel cardiovascular magnetic resonance techniques.
Lehmonen L; Kaasalainen T; Atula S; Mustonen T; Holmström M
Int J Cardiovasc Imaging; 2019 Feb; 35(2):351-358. PubMed ID: 30848402
[TBL] [Abstract][Full Text] [Related]
22. Cardiac remodelling identified by cardiovascular magnetic resonance in patients with hepatitis C infection and liver disease.
Ngu PJ; Butler M; Pham A; Roberts SK; Taylor AJ
Int J Cardiovasc Imaging; 2016 Apr; 32(4):629-36. PubMed ID: 26667447
[TBL] [Abstract][Full Text] [Related]
23. Therapeutic value of tafamidis in patients with wild-type transthyretin amyloidosis (ATTRwt) with cardiomyopathy based on cardiovascular magnetic resonance (CMR) imaging.
Chamling B; Bietenbeck M; Korthals D; Drakos S; Vehof V; Stalling P; Meier C; Yilmaz A
Clin Res Cardiol; 2023 Mar; 112(3):353-362. PubMed ID: 35666277
[TBL] [Abstract][Full Text] [Related]
24. Myocardial tissue remodeling after orthotopic heart transplantation: a pilot cardiac magnetic resonance study.
Coelho-Filho OR; Shah R; Lavagnoli CFR; Barros JC; Neilan TG; Murthy VL; de Oliveira PPM; Souza JRM; de Oliveira Severino ESB; de Souza Vilarinho KA; da Mota Silveira Filho L; Garcia J; Semigran MJ; Coelho OR; Jerosch-Herold M; Petrucci O
Int J Cardiovasc Imaging; 2018 Jan; 34(1):15-24. PubMed ID: 27437924
[TBL] [Abstract][Full Text] [Related]
25. Myocardial tissue characterization by contrast-enhanced cardiac magnetic resonance imaging in subjects with prediabetes, diabetes, and normal controls with preserved ejection fraction from the general population.
Storz C; Hetterich H; Lorbeer R; Heber SD; Schafnitzel A; Patscheider H; Auweter S; Zitzelsberger T; Rathmann W; Nikolaou K; Reiser M; Schlett CL; von Knobelsdorff-Brenkenhoff F; Peters A; Schulz-Menger J; Bamberg F
Eur Heart J Cardiovasc Imaging; 2018 Jun; 19(6):701-708. PubMed ID: 28950340
[TBL] [Abstract][Full Text] [Related]
26. CMR-derived extracellular volume fraction (ECV) in asymptomatic heart transplant recipients: correlations with clinical features and myocardial edema.
Yuan Y; Cai J; Cui Y; Wang J; Alwalid O; Shen X; Cao Y; Zou Y; Liang B
Int J Cardiovasc Imaging; 2018 Dec; 34(12):1959-1967. PubMed ID: 30056496
[TBL] [Abstract][Full Text] [Related]
27. Late gadolinium enhancement in cardiac amyloidosis: attributable both to interstitial amyloid deposition and subendocardial fibrosis caused by ischemia.
Hashimura H; Ishibashi-Ueda H; Yonemoto Y; Ohta-Ogo K; Matsuyama TA; Ikeda Y; Morita Y; Yamada N; Yasui H; Naito H
Heart Vessels; 2016 Jun; 31(6):990-5. PubMed ID: 25794983
[TBL] [Abstract][Full Text] [Related]
28. Characterizing cardiac involvement in amyloidosis using cardiovascular magnetic resonance diffusion tensor imaging.
Gotschy A; von Deuster C; van Gorkum RJH; Gastl M; Vintschger E; Schwotzer R; Flammer AJ; Manka R; Stoeck CT; Kozerke S
J Cardiovasc Magn Reson; 2019 Sep; 21(1):56. PubMed ID: 31484544
[TBL] [Abstract][Full Text] [Related]
29. Relative Apical Sparing of Myocardial Longitudinal Strain Is Explained by Regional Differences in Total Amyloid Mass Rather Than the Proportion of Amyloid Deposits.
Bravo PE; Fujikura K; Kijewski MF; Jerosch-Herold M; Jacob S; El-Sady MS; Sticka W; Dubey S; Belanger A; Park MA; Di Carli MF; Kwong RY; Falk RH; Dorbala S
JACC Cardiovasc Imaging; 2019 Jul; 12(7 Pt 1):1165-1173. PubMed ID: 30121266
[TBL] [Abstract][Full Text] [Related]
30. Cardiovascular magnetic resonance in cardiac amyloidosis.
Maceira AM; Joshi J; Prasad SK; Moon JC; Perugini E; Harding I; Sheppard MN; Poole-Wilson PA; Hawkins PN; Pennell DJ
Circulation; 2005 Jan; 111(2):186-93. PubMed ID: 15630027
[TBL] [Abstract][Full Text] [Related]
31. Increased myocardial native T1 and extracellular volume in patients with Duchenne muscular dystrophy.
Soslow JH; Damon SM; Crum K; Lawson MA; Slaughter JC; Xu M; Arai AE; Sawyer DB; Parra DA; Damon BM; Markham LW
J Cardiovasc Magn Reson; 2016 Jan; 18():5. PubMed ID: 26795569
[TBL] [Abstract][Full Text] [Related]
32. [Late gadolinium enhancement and T1 mapping for the diagnosis of cardiac amyloidosis].
Cui Q; Yu J; Shen W
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Dec; 31(12):1538-1541. PubMed ID: 32029045
[TBL] [Abstract][Full Text] [Related]
33. Markedly increased volume of distribution of gadolinium in cardiac amyloidosis demonstrated by T1 mapping.
Brooks J; Kramer CM; Salerno M
J Magn Reson Imaging; 2013 Dec; 38(6):1591-5. PubMed ID: 23450747
[TBL] [Abstract][Full Text] [Related]
34. Extracellular volume fraction is more closely associated with altered regional left ventricular velocities than left ventricular ejection fraction in nonischemic cardiomyopathy.
Collins J; Sommerville C; Magrath P; Spottiswoode B; Freed BH; Benzuly KH; Gordon R; Vidula H; Lee DC; Yancy C; Carr J; Markl M
Circ Cardiovasc Imaging; 2015 Jan; 8(1):. PubMed ID: 25552491
[TBL] [Abstract][Full Text] [Related]
35. Comprehensive validation of cardiovascular magnetic resonance techniques for the assessment of myocardial extracellular volume.
Miller CA; Naish JH; Bishop P; Coutts G; Clark D; Zhao S; Ray SG; Yonan N; Williams SG; Flett AS; Moon JC; Greiser A; Parker GJ; Schmitt M
Circ Cardiovasc Imaging; 2013 May; 6(3):373-83. PubMed ID: 23553570
[TBL] [Abstract][Full Text] [Related]
36. Native T1 and Extracellular Volume in Transthyretin Amyloidosis.
Martinez-Naharro A; Kotecha T; Norrington K; Boldrini M; Rezk T; Quarta C; Treibel TA; Whelan CJ; Knight DS; Kellman P; Ruberg FL; Gillmore JD; Moon JC; Hawkins PN; Fontana M
JACC Cardiovasc Imaging; 2019 May; 12(5):810-819. PubMed ID: 29550324
[TBL] [Abstract][Full Text] [Related]
37. Assessment of diffuse myocardial fibrosis in rats using small-animal Look-Locker inversion recovery T1 mapping.
Messroghli DR; Nordmeyer S; Dietrich T; Dirsch O; Kaschina E; Savvatis K; O h-Ici D; Klein C; Berger F; Kuehne T
Circ Cardiovasc Imaging; 2011 Nov; 4(6):636-40. PubMed ID: 21917782
[TBL] [Abstract][Full Text] [Related]
38. Myocardial tissue characterization and strain analysis in healthy pregnant women using cardiovascular magnetic resonance native T1 mapping and feature tracking technique.
Nii M; Ishida M; Dohi K; Tanaka H; Kondo E; Ito M; Sakuma H; Ikeda T
J Cardiovasc Magn Reson; 2018 Aug; 20(1):52. PubMed ID: 30068369
[TBL] [Abstract][Full Text] [Related]
39. Quantification of extracellular matrix expansion by CMR in infiltrative heart disease.
Mongeon FP; Jerosch-Herold M; Coelho-Filho OR; Blankstein R; Falk RH; Kwong RY
JACC Cardiovasc Imaging; 2012 Sep; 5(9):897-907. PubMed ID: 22974802
[TBL] [Abstract][Full Text] [Related]
40. Fat deposition in dilated cardiomyopathy assessed by CMR.
Lu M; Zhao S; Jiang S; Yin G; Wang C; Zhang Y; Liu Q; Cheng H; Ma N; Zhao T; Chen X; Huang J; Zou Y; Song L; He Z; An J; Renate J; Xue H; Shah S
JACC Cardiovasc Imaging; 2013 Aug; 6(8):889-98. PubMed ID: 23850250
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
